Osteoben® is formulated to address the pathophysiology of osteopenia and osteoporosis, providing patients with the proper bone-supportive nutritional requirements in order to safely assist with the dietary management of these conditions. The main active compound of Osteoben® is the isoflavone genistein, which works to target the decreased BMD (bone mineral density) seen in osteopenia and osteoporosis.
Made with non-GMO ingredients.
Many epidemiological studies have been conducted demonstrating that high isoflavone intake has bone-sparing effects. Research suggests that genistein exerts its effect by managing the metabolic imbalance in bone tissue induced by ovarian hormone depletion, an important fact since the primary type of osteoporosis affects postmenopausal women. Genistein is a phytoestrogen that acts as a mild SERM (selective estrogen receptor modulator) which may positively regulate bone cell metabolism without serious side effects.
The genistein aglycone in Osteoben is from a non-soy plant source.